Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ForouzanfarMHForemanKJDelossantosAMBreast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysisLancet201137898011461148421924486
   PubMed Web of Science ®Google Scholar
• MaguireRKotronoulasGSimpsonMPatersonCA systematic review of the supportive care needs of women living with and beyond cervical cancerGynecol Oncol2015136347849025462200
   PubMed Web of Science ®Google Scholar
• zur HausenHHuman papillomaviruses in the pathogenesis of anogenital cancerVirology199118419131651607
   PubMed Web of Science ®Google Scholar
• OjesinaAILichtensteinLFreemanSSLandscape of genomic alterations in cervical carcinomasNature2014506748837137524390348
   PubMed Web of Science ®Google Scholar
• ZhaiYKuickRNanBGene expression analysis of prein-vasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasionCancer Res20076721101631017217974957
   PubMed Web of Science ®Google Scholar
• ScottoLNarayanGNandulaSVIdentification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progressionGenes Chromosomes Cancer200847975576518506748
   PubMed Web of Science ®Google Scholar
• den BoonJAPyeonDWangSSMolecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signalingProc Natl Acad Sci U S A201511225E3255E326426056290
   PubMedGoogle Scholar
• PappaKIPolyzosAJacob-HirschJProfiling of discrete gyne-cological cancers reveals novel transcriptional modules and common features shared by other cancer types and embryonic stem cellsPLoS One20151011e014222926559525
   PubMed Web of Science ®Google Scholar
• LeischingGRLoosBBothaMHEngelbrechtAMThe role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancerToxicology2015335727826201060
   PubMed Web of Science ®Google Scholar
• TewariKSSillMWLongHJImproved survival with bevacizumab in advanced cervical cancerN Engl J Med2014370873474324552320
   PubMed Web of Science ®Google Scholar
• KatanyooKTangjitgamolSChongthanakornMTreatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patientsGynecol Oncol2011123357157621955483
   PubMed Web of Science ®Google Scholar
• WangXShenYZhaoYAdjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: a phase II trialEur J Surg Oncol20154181082108826033265
   PubMed Web of Science ®Google Scholar
• DownsLSChuraJCArgentaPAIfosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trialGynecol Oncol2011120226526921145100
   PubMed Web of Science ®Google Scholar
• MuderspachLIBlessingJALevenbackCMooreJLJrA phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group studyGynecol Oncol200181221321511354055
   PubMed Web of Science ®Google Scholar
• EskanderRNTewariKSChemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancerCurr Opin Obstet Gynecol201426431432124979076
   PubMed Web of Science ®Google Scholar
• LorussoDPetrelliFCoinuARaspagliesiFBarniSA systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancerGynecol Oncol2014133111712324486604
   PubMed Web of Science ®Google Scholar
• YehCTWuATChangPMTrifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancerAm J Respir Crit Care Med2012186111180118823024022
   PubMed Web of Science ®Google Scholar
• ChenMHLinKJYangWLGene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinomaCancer2013119229330322810956
   PubMed Web of Science ®Google Scholar
• HassaneDCGuzmanMLCorbettCDiscovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression dataBlood2008111125654566218305216
   PubMed Web of Science ®Google Scholar
• LambJCrawfordEDPeckDThe Connectivity Map: using gene-expression signatures to connect small molecules, genes, and diseaseScience200631357951929193517008526
   PubMed Web of Science ®Google Scholar
• GautierLCopeLBolstadBMIrizarryRAaffy – analysis of Affyme-trix GeneChip data at the probe levelBioinformatics200420330731514960456
   PubMed Web of Science ®Google Scholar
• RitchieMEPhipsonBWuDlimma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Res2015437e4725605792
   PubMed Web of Science ®Google Scholar
• YuGWangLGHanYHeQYclusterProfiler: an R package for comparing biological themes among gene clustersOMICS201216528428722455463
   PubMed Web of Science ®Google Scholar
• ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
   PubMed Web of Science ®Google Scholar
• SzklarczykDMorrisJHCookHThe STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessibleNucleic Acids Res201745D1D362D36827924014
   PubMed Web of Science ®Google Scholar
• TangZLiCKangBGaoGLiCZhangZGEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Res201745W1W98W10228407145
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkWeinsteinJNCollissonEAMillsGBThe Cancer Genome Atlas Pan-Cancer analysis projectNat Genet201345101113112024071849
   PubMed Web of Science ®Google Scholar
• GTEx ConsortiumThe Genotype-Tissue Expression (GTEx) projectNat Genet201345658058523715323
   PubMed Web of Science ®Google Scholar
• WangYLiYZhangWYmRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinomaEur J Cancer Prev2009181404519077563
   PubMed Web of Science ®Google Scholar
• SzelachowskaJDziegielPJelen-KrzeszewskaJCorrelation of metallothionein expression with clinical progression of cancer in the oral cavityAnticancer Res200929258959519331208
   PubMed Web of Science ®Google Scholar
• GakiopoulouHKorkolopoulouPLevidouGMinichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implicationsBr J Cancer20079781124113417940502
   PubMed Web of Science ®Google Scholar
• BurgerMDenzingerSHartmannAWielandWFStoehrRObermannECMcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological gradeBr J Cancer200796111711171517505513
   PubMed Web of Science ®Google Scholar
• ZhangXTengYYangFMCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomasOncol Rep20153352599260525738322
   PubMed Web of Science ®Google Scholar
• ZhengJDiagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infectionInt J Clin Exp Pathol20158187588025755789
   PubMed Web of Science ®Google Scholar
• Amaro FilhoSMNuovoGJCunhaCBCorrelation of MCM2 detection with stage and virology of cervical cancerInt J Biol Markers2014294e363e37124706378
   PubMed Web of Science ®Google Scholar
• TachibanaKEGonzalezMAColemanNCell-cycle-dependent regulation of DNA replication and its relevance to cancer pathologyJ Pathol2005205212312915643673
   PubMed Web of Science ®Google Scholar
• ZhaoHLoYHMaLTargeting tyrosine phosphorylation of PCNA inhibits prostate cancer growthMol Cancer Ther2011101293621220489
   PubMed Web of Science ®Google Scholar
• WangLFChaiCYKuoWRTaiCFLeeKWHoKYCorrelation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinomaAm J Otolaryngol200627210110516500472
   PubMed Web of Science ®Google Scholar
• LvQZhangJYiYProliferating cell nuclear antigen has an association with prognosis and risks factors of cancer patients: a systematic reviewMol Neurobiol20165396209621726558632
   PubMed Web of Science ®Google Scholar
• AraiMKondohNImazekiNThe knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cellsLiver Int2009291556218492021
   PubMed Web of Science ®Google Scholar
• SrihariSKalimuthoMLalSUnderstanding the functional impact of copy number alterations in breast cancer using a network modeling approachMol Biosyst201612396397226805938
   PubMedGoogle Scholar
• XiangJFangLLuoYLevels of human replication factor C4, a clamp loader, correlate with tumor progression and predict the prognosis for colorectal cancerJ Transl Med20141232025407051
   PubMed Web of Science ®Google Scholar
• MineKLShulzhenkoNYambartsevAGene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancerNat Commun20134180623651994
   PubMed Web of Science ®Google Scholar
• XuXPageJLSurteesJABroad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasmsCancer Res20086882652266018413732
   PubMed Web of Science ®Google Scholar
• KangWTongJHChanAWTargeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinomaOncol Rep20143162579258624756820
   PubMed Web of Science ®Google Scholar
• DuxburyMSWhangEERRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasivenessBiochem Biophys Res Commun2007354119019617222798
   PubMed Web of Science ®Google Scholar
• WangNLiYZhouJDownregulation of ribonucleotide reductase subunits M2 induces apoptosis and G1 arrest of cervical cancer cellsOncol Lett20181533719372529556274
   PubMed Web of Science ®Google Scholar
• FerrandinaGMeyVNannizziSExpression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancerCancer Chemother Pharmacol201065467968619639316
   PubMed Web of Science ®Google Scholar
• MorikawaTMaedaDKumeHHommaYFukayamaMRibonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancerHistopathology201057688589221166702
   PubMed Web of Science ®Google Scholar
• KretschmerCSterner-KockASiedentopfFSchoeneggWSchlagPMKemmnerWIdentification of early molecular markers for breast cancerMol Cancer20111011521314937
   PubMedGoogle Scholar
• SuYFWuTFKoJLThe expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patientsPLoS One201493e9164424637958
   PubMed Web of Science ®Google Scholar
• van DamPAvan DamPJRolfoCIn silico pathway analysis in cervical carcinoma reveals potential new targets for treatmentOncotarget2016732780279526701206
   PubMedGoogle Scholar
• LiXTianRGaoHIdentification of significant gene signatures and prognostic biomarkers for patients with cervical cancer by integrated bioinformatic methodsTechnol Cancer Res Treat201817112
   Web of Science ®Google Scholar
• RanganathanPRangnekarVMExploiting the TSA connections to overcome apoptosis-resistanceCancer Biol Ther20054439139215908800
   PubMed Web of Science ®Google Scholar
• HajjiNWallenborgKVlachosPNymanUHermansonOJosephBCombinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cellsOncogene200827223134314418071312
   PubMed Web of Science ®Google Scholar
• VanhaeckeTPapeleuPElautGRogiersVTrichostatin A-like hydroxa-mate histone deacetylase inhibitors as therapeutic agents: toxicological point of viewCurr Med Chem200411121629164315180568
   PubMed Web of Science ®Google Scholar
• YouBRParkWHTrichostatin A induces apoptotic cell death of HeLa cells in a Bcl-2 and oxidative stress-dependent mannerInt J Oncol201342135936623165748
   PubMed Web of Science ®Google Scholar
• DuvicMVuJVorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphomaExpert Opin Investig Drugs200716711111120
   PubMed Web of Science ®Google Scholar
• HeHLiuXWangDSAHA inhibits the transcription initiation of HPV18 E6/E7 genes in HeLa cervical cancer cellsGene201455329810425300249
   PubMed Web of Science ®Google Scholar
• XingJWangHXuSHanPXinMZhouJLSensitization of suberoylanilide hydroxamic acid (SAHA) on chemoradiation for human cervical cancer cells and its mechanismEur J Gynaecol Oncol201536211712226050346
   PubMed Web of Science ®Google Scholar
• Gil-AdIShtaifBLevkovitzYPhenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growthOncol Rep200615110711216328041
   PubMed Web of Science ®Google Scholar
• LiJYaoQYXueJSDopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancerActa Pharmacol Sin20173891282129628649130
   PubMed Web of Science ®Google Scholar
• SeoSUChoHKMinKJThioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expressionCell Death Dis201782e259928182008
   PubMedGoogle Scholar
• KangSDongSMKimBRThioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cellsApoptosis201217998999722460505
   PubMed Web of Science ®Google Scholar